We are live on
!
Find out more
MCM
Mitchell Capital Management Portfolio holdings
AUM
$657M
1-Year Est. Return
64.28%
This Fund
S&P 500
This Quarter
Est. Return
+7.08%
1 Year Est. Return
+64.28%
3 Year Est. Return
+219.19%
5 Year Est. Return
+290.67%
10 Year Est. Return
+1,411.54%
AUM
$277M
AUM Growth
+$143K
(+0.05%)
Cap. Flow
-$15.8M
Cap. Flow
% of AUM
-5.71%
Top 10 Holdings %
Top 10 Hldgs %
31.67%
Holding
118
New
8
Increased
57
Reduced
36
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$4.34M |
| 2 |
EPAM Systems
EPAM
|
+$1.5M |
| 3 |
Martin Marietta Materials
MLM
|
+$1.46M |
| 4 |
Marathon Petroleum
MPC
|
+$940K |
| 5 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$930K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$5.17M |
| 2 |
Ormat Technologies
ORA
|
+$5.15M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.92M |
| 4 |
Starbucks
SBUX
|
+$4.38M |
| 5 |
Royal Caribbean
RCL
|
+$3.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.39% |
| 2 | Financials | 17.89% |
| 3 | Industrials | 14.43% |
| 4 | Healthcare | 12.99% |
| 5 | Consumer Discretionary | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
CME Group
CME
$94.3B
| $1.03M | 0.37% |
6,293
+1,742
| +38% | +$285K |
|
52
Sysco
SYY
$40.5B
| $1.03M | 0.37% |
15,038
+11,695
| +350% | +$747K |
|
53
Amgen
AMGN
$226B
| $1.01M | 0.37% |
5,498
+3,627
| +194% | +$642K |
|
54
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.88B
| $993K | 0.36% |
40,230
+958
| +2% | +$24.7K |
|
55
Schwab US Mid-Cap ETF
SCHM
$15.3B
| $936K | 0.34% |
51,156
+1,167
| +2% | +$21.1K |
|
56
Walt Disney
DIS
$181B
| $920K | 0.33% |
8,778
+4,521
| +106% | +$462K |
|
57
State Street
STT
$52.2B
| $912K | 0.33% |
9,798
+2,598
| +36% | +$258K |
|
|
58
Marathon Petroleum
MPC
$100B
| $864K | 0.31% |
+12,309
| New | +$940K |
|
59
Truist Financial
TFC
$64.7B
| $860K | 0.31% |
17,059
+3,820
| +29% | +$203K |
|
60
Medtronic
MDT
$116B
| $815K | 0.29% |
9,516
+4,978
| +110% | +$416K |
|
61
Oracle
ORCL
$450B
| $804K | 0.29% |
18,257
+4,106
| +29% | +$189K |
|
62
Johnson & Johnson
JNJ
$632B
| $788K | 0.28% |
6,496
+1,623
| +33% | +$202K |
|
63
Danaher
DHR
$145B
| $786K | 0.28% |
8,981
+2,159
| +32% | +$192K |
|
64
Zimmer Biomet
ZBH
$18.7B
| $778K | 0.28% |
7,195
+1,864
| +35% | +$203K |
|
65
Kohl's
KSS
$2.22B
| $714K | 0.26% |
9,790
+2,608
| +36% | +$174K |
|
66
Elbit Systems
ESLT
$36.5B
| $686K | 0.25% |
5,778
+1,819
| +46% | +$216K |
|
67
Accenture
ACN
$109B
| $677K | 0.24% |
4,140
+1,182
| +40% | +$184K |
|
68
FedEx
FDX
$80.3B
| $673K | 0.24% |
2,965
+790
| +36% | +$196K |
|
69
Aon
AON
$75.7B
| $659K | 0.24% |
4,805
+1,351
| +39% | +$190K |
|
70
Cognizant
CTSH
$26.7B
| $642K | 0.23% |
+8,128
| New | +$639K |
|
71
Diageo
DEO
$52.8B
| $641K | 0.23% |
4,454
+1,961
| +79% | +$281K |
|
72
Schwab U.S Small- Cap ETF
SCHA
$23.5B
| $625K | 0.23% |
33,968
+796
| +2% | +$14.4K |
|
73
iShares Core MSCI Total International Stock ETF
IXUS
$60.8B
| $603K | 0.22% |
10,031
-1,851
| -16% | -$116K |
|
74
AstraZeneca
AZN
$244B
| $598K | 0.22% |
8,511
+1,959
| +30% | +$141K |
|
75
iShares Core S&P Mid-Cap ETF
IJH
$128B
| $588K | 0.21% |
15,095
-2,305
| -13% | -$89K |
|
Similar funds
BL
PIM
ACM
PAI
DC
FAM
AG
BCP
Mitchell Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Mitchell Capital Management held 118 positions worth $277M, up 0.05% from $277M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Mitchell Capital Management withdrew a net $15.8M in Q2 2018, closing 15 positions and reducing 36 holdings. Its most notable exit was Citigroup, an estimated $5.17M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
Against the trend, Mitchell Capital Management opened a new position in PRA Health Sciences, Inc. worth $4.71M.
- Mitchell Capital Management's largest Q2 2018 buy was PRA Health Sciences, Inc.: 50,433 shares worth $4.71M.
- Mitchell Capital Management added most to EPAM Systems in Q2 2018, an estimated $1.5M increase.
- Mitchell Capital Management's biggest Q2 2018 reduction was Alphabet (Google) Class C, cutting an estimated $4.92M.
- Mitchell Capital Management fully exited Citigroup in Q2 2018, selling an estimated $5.17M.
- Mitchell Capital Management's ten largest holdings make up 32% of its $277M portfolio in Q2 2018.
- Mitchell Capital Management opened 8 new positions and closed 15 in Q2 2018.
- Mitchell Capital Management's portfolio value rose 0.05% quarter-over-quarter to $277M.
Based on Mitchell Capital Management's 13F filing for Q2 2018, filed 10 Aug 2018.